Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trialBruno François, Richard S. Hotchkiss, Robin Jeannet et al.|JCI Insight|2018Cited by 412
Immunotherapies for COVID-19: lessons learned from sepsisKenneth E. Remy, Lyle L. Moldawer, Scott C. Brakenridge et al.|The Lancet Respiratory Medicine|2020Cited by 165
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)Pierre François Laterre, Richard S. Hotchkiss, Bruno François et al.|JAMA Network Open|2020Cited by 98
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppressionRobin Jeannet, Bruno François, Thomas Daix et al.|Intensive Care Medicine|2020Cited by 92
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trialThomas Daix, Bruno François, Armelle Mathonnet et al.|Annals of Intensive Care|2023Cited by 76